Abstract:Background Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM-5) is a well-characterized biomarker for the clinical diagnosis of various cancers. Nanobodies, considered the smallest antibody fragments with intact antigen-binding capacity, have gained significant attention in disease diagnosis and therapy. Due to their peculiar properties, nanobodies have become promising alternative diagnostic reagents in immunoassay. However, nanobodies-based immunoassay is still hindered by small molecular size and low antigen capture efficacy. Therefore, there is a pressing need to develop novel nanobody-based immunoassays with superior performance. Results A novel pentameric nanobodies-based immunoassay (PNIA) was developed with enhanced sensitivity and specificity for CEACAM-5 detection. The binding epitopes of three anti-CEACAM-5 nanobodies (Nb1, Nb2 and Nb3) were analyzed. To enhance the capture and detection efficacy of CEACAM-5 in the immunoassay, we engineered bispecific nanobodies (Nb1–Nb2-rFc) as the capture antibody, and developed the FITC-labeled pentameric nanobodies (Nb3-VT1B) as the detection antibody. The binding affinities of Nb1–Nb2-rFc (1.746 × 10 −10 ) and Nb3-VT1B (1.279 × 10 −11 ) were significantly higher than those of unmodified nanobodies (Nb1-rFc, 4.063 × 10 −9 ; Nb2-rFc, 2.136 × 10 −8 ; Nb3, 3.357 × 10 −9 ). The PNIA showed a linear range of 0.625–160 ng mL −1 with a correlation coefficient R 2 of 0.9985, and a limit of detection of 0.52 ng mL −1 , which was 24-fold lower than the immunoassay using monomeric nanobody. The PNIA was validated with the spiked human serum. The average recoveries ranged from 91.8% to 102% and the coefficients of variation ranged from 0.026% to 0.082%. Significance and novelty The advantages of nanobodies offer a promising alternative to conventional antibodies in disease diagnosis. The novel PNIA demonstrated superior sensitivity and high specificity for the detection of CEACAM-5 antigen. This bispecific or multivalent nanobody design will provide some new insights into the design of immunoassays for clinical diagnosis.

Development of a self-assembled heptameric nanobody/streptavidin-binding peptide fusion for ultrasensitive detection of serum biomarkers

Development of a nanobody tagged with streptavidin-binding peptide and its application in a Luminex fluoroimmunoassay for alpha fetal protein in serum

Nanobody based immunoassay for alpha fetal protein detection using streptavidin-conjugated polymerized horseradish peroxidase for signal amplification

An innovative electrochemical immunosensor based on nanobody heptamer and AuNPs@ZIF-8 nanocomposites as support for the detection of alpha fetoprotein in serum

Ultrasensitive dynamic light scattering immunodetection of alpha-fetoprotein using heptamer-amplified nanoparticle crosslinking aggregation

Generation of a nanobody-alkaline phosphatase fusion and its application in an enzyme cascade-amplified immunoassay for colorimetric detection of alpha fetoprotein in human serum

Aptameric System for the Highly Selective and Ultrasensitive Detection of Protein in Human Serum Based on Non-Stripping Gold Nanoparticles

Electrostatic Nanocage-Confined Probe for Electrochemical Detection of CA19-9 in Human Serum.

Development of active affibody aggregates induced by a self-assembling peptide for high sensitive detection of alpha-fetoprotein

A SERS-based immunoassay for the detection of alpha-fetoprotein using AuNS@Ag@SiO2 core-shell nanostars

Sensitive Detection Of Protein Biomarkers Using Silver Nanoparticles Enhanced Immunofluorescence Assay

A Universal and Enzyme-Free Immunoassay Platform for Biomarker Detection Based on Gold Nanoparticle Enumeration with a Dark-Field Microscope

Label-free Detection of Biomarker Alpha Fetoprotein in Serum by Ssdna Aptamer Functionalized Magnetic Nanoparticles.

Enzyme-free ECL Immunesensor Based on PbS Nanocrystals for Highly Sensitive Detection of Alpha Fetoprotein

Ps − Pt nanozyme-based synergistic signal amplification biosensor for highly sensitive colorimetric detection of protein

Development of a highly sensitive immunoassay based on pentameric nanobodies for carcinoembryonic antigen detection

Competitive Aptasensor for the Ultrasensitive Multiplexed Detection of Cancer Biomarkers by Fluorescent Nanoparticle Counting.

Rapid and sensitive detection of heart-type fatty acid binding protein using aggregation-induced emission nanoparticles on digital microfluidics workstation

Enzyme-free Amplified SERS Immunoassay for the Ultrasensitive Detection of Disease Biomarkers.

Surface-enhanced Raman scatting microfluidic chip based on the identification competition strategy were used for rapid and simultaneous detection of liver cancer related proteins

A chemiluminescence immunosensor for biomarker detection based on boronic acid-modified magnetic composite microspheres